Squarepoint Ops LLC Tango Therapeutics, Inc. Transaction History

Squarepoint Ops LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$6.66 - $10.15 $339,926 - $518,056	-51,040 Reduced 78.28%	14,158 $121,000
Q1 2024 May 15, 2024	SELL	$7.51 - $12.88 $259,921 - $445,776	-34,610 Reduced 34.68%	65,198 $517,000
Q4 2023 Feb 14, 2024	BUY	$6.52 - $12.01 $387,887 - $714,498	59,492 Added 147.56%	99,808 $988,000
Q2 2023 Aug 14, 2023	SELL	$2.67 - $4.7 $139,966 - $246,383	-52,422 Reduced 56.53%	40,316 $133,000
Q1 2023 May 15, 2023	BUY	$3.76 - $8.06 $348,694 - $747,468	92,738 New	92,738 $366,000
Q3 2022 Nov 14, 2022	BUY	$3.25 - $5.46 $90,931 - $152,765	27,979 New	27,979 $101,000
Q2 2022 Aug 15, 2022	SELL	$3.86 - $8.01 $322,522 - $669,275	-83,555 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$7.01 - $10.94 $585,720 - $914,091	83,555 New	83,555 $633,000

123

91.7M

3.1K

1.5K

Ticker TNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 88,067,296
Market Cap $359M
Description
Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.